Dimerix

Dimerix (DXB)

Stock Code

DXB

Stock Exchange

Australian Securities Exchange

Dimerix (DXB) shares was listed on the Australian Stock Exchange (ASX) on February 4, 1993 and is in the Health Care sector. DIMERIX LIMITED is a clinical stage, biotechnology company. The Company is focused on developing new therapeutics discovered using its proprietary drug development platform, Receptor-Heteromer Investigation Technology (HIT).

Our lead therapy DMX-200 is currently in Phase II clinical trials for chronic kidney disease and has received US Orphan Drug Designation for Focal Segmental Glomerulosclerosis (FSGS).

Syndicate content

Recommended Websites